Savior LLC’s Veracyte VCYT Stock Holding History

Savior LLC’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-58	Closed	-$2K	–	757
2021 Q2	$2K	Hold	58	–	–	﹤0.01%	760
2021 Q1	$3K	Hold	58	–	–	﹤0.01%	718
2020 Q4	$3K	Hold	58	–	–	﹤0.01%	690
2020 Q3	$2K	Hold	58	–	–	﹤0.01%	720
2020 Q2	$2K	Hold	58	–	–	﹤0.01%	683
2020 Q1	$1K	Hold	58	–	–	﹤0.01%	764
2019 Q4	$2K	Buy	+58	New	+$1.5K	﹤0.01%	784

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Savior LLC's VCYT Position: Q3 2021 in Review

Savior LLC sold out of Veracyte (VCYT) in Q3 2021, closing a stake of 58 shares — an estimated $2K sold.

Savior LLC first reported a position in VCYT in Q4 2019 and held it in 7 quarters. The position peaked at $3K in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q3 2021.

Savior LLC reported no remaining Veracyte position as of Q3 2021 after selling out during the quarter.
Savior LLC sold 58 Veracyte shares in Q3 2021, an estimated $2K.
Savior LLC first reported a position in Veracyte in Q4 2019 and held it in 7 quarters.
Savior LLC's Veracyte position peaked at $3K in Q1 2021.
214 funds tracked by Wall St. Rank held Veracyte as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.